@Phaedrus Thanks mate I think it answers all of my questions. If my reading is correct then assay submission is classified as a Class 1 Resubmission which has a 2-month review period.This in turn would meand that the best announcement we can get in the coming days is that FDA has set a target goal date sometime in May this year for a determination on gvhd for kids. We'll find it in short order indeed.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-263
-
-
- There are more pages in this discussion • 287 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.01 |
Change
-0.020(1.95%) |
Mkt cap ! $1.164B |
Open | High | Low | Value | Volume |
$1.03 | $1.04 | $1.01 | $2.277M | 2.221M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 179090 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 171902 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 216283 | 1.005 |
39 | 562463 | 1.000 |
19 | 208840 | 0.995 |
19 | 325707 | 0.990 |
11 | 554874 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 163768 | 21 |
1.015 | 54951 | 16 |
1.020 | 97859 | 21 |
1.025 | 46510 | 9 |
1.030 | 47075 | 8 |
Last trade - 11.29am 24/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online